Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral midazolam solution vs oral midazolam injection vs intranasal dexmedetomidine for premedication in pediatric dental GA
ChiCTR2200066737Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of midazolam and dexmedetomidine in Dental anxiety, Procedural anxiety and carious lesion (3 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Sedation success rate. Started Nov 2022; status: recruiting.
02
Drugs
midazolamdexmedetomidine
03
Conditions
Dental anxietyProcedural anxietycarious lesion
Beyond the preview
Go deeper on ChiCTR2200066737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066737.